"Diarrhea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Descriptor ID |
D003967
|
| MeSH Number(s) |
C23.888.821.214
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diarrhea".
Below are MeSH descriptors whose meaning is more specific than "Diarrhea".
This graph shows the total number of publications written about "Diarrhea" by people in this website by year, and whether "Diarrhea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 1 | 3 | 4 |
| 1996 | 1 | 6 | 7 |
| 1997 | 1 | 5 | 6 |
| 1998 | 4 | 1 | 5 |
| 1999 | 4 | 6 | 10 |
| 2000 | 6 | 3 | 9 |
| 2001 | 9 | 2 | 11 |
| 2002 | 2 | 6 | 8 |
| 2003 | 4 | 5 | 9 |
| 2004 | 3 | 4 | 7 |
| 2005 | 6 | 8 | 14 |
| 2006 | 11 | 4 | 15 |
| 2007 | 9 | 8 | 17 |
| 2008 | 10 | 8 | 18 |
| 2009 | 9 | 5 | 14 |
| 2010 | 12 | 11 | 23 |
| 2011 | 5 | 13 | 18 |
| 2012 | 5 | 7 | 12 |
| 2013 | 4 | 13 | 17 |
| 2014 | 13 | 8 | 21 |
| 2015 | 10 | 11 | 21 |
| 2016 | 8 | 7 | 15 |
| 2017 | 7 | 15 | 22 |
| 2018 | 8 | 7 | 15 |
| 2019 | 8 | 7 | 15 |
| 2020 | 6 | 10 | 16 |
| 2021 | 6 | 5 | 11 |
| 2022 | 0 | 17 | 17 |
| 2023 | 1 | 12 | 13 |
| 2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diarrhea" by people in Profiles.
-
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies. Cancer Res Commun. 2024 02 12; 4(2):378-387.
-
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease. J Clin Invest. 2024 Jan 16; 134(2).
-
Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes. Oncologist. 2024 Jan 05; 29(1):36-46.
-
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer Res Commun. 2023 12 19; 3(12):2572-2584.
-
Rotavirus-mediated DGAT1 degradation: A pathophysiological mechanism of viral-induced malabsorptive diarrhea. Proc Natl Acad Sci U S A. 2023 Dec 19; 120(51):e2302161120.
-
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2. Ann Oncol. 2023 12; 34(12):1131-1140.
-
Epidemiology of giardiasis and assemblages A and B and effects on diarrhea and growth trajectories during the first 8 years of life: Analysis of a birth cohort in a rural district in tropical Ecuador. PLoS Negl Trop Dis. 2023 Nov; 17(11):e0011777.
-
The potential for development of clinically relevant microbial resistance to rifaximin-a: a narrative review. Clin Microbiol Rev. 2023 12 20; 36(4):e0003923.
-
Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy. J Travel Med. 2023 10 31; 30(6).
-
Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial. Lancet. 2023 11 04; 402(10413):1627-1635.